These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2817214)

  • 1. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Cohen WH; Gentry MK; Timchak RL; Burke DS; Eckels KH
    Am J Trop Med Hyg; 1989 Nov; 41(5):576-80. PubMed ID: 2817214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.
    Beltramello M; Williams KL; Simmons CP; Macagno A; Simonelli L; Quyen NT; Sukupolvi-Petty S; Navarro-Sanchez E; Young PR; de Silva AM; Rey FA; Varani L; Whitehead SS; Diamond MS; Harris E; Lanzavecchia A; Sallusto F
    Cell Host Microbe; 2010 Sep; 8(3):271-83. PubMed ID: 20833378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
    Gelanew T; Hunsperger E
    Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    Henchal EA; Henchal LS; Schlesinger JJ
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2101-7. PubMed ID: 3404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
    Gelanew T; Poole-Smith BK; Hunsperger E
    J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive protection assay of monoclonal antibodies against dengue virus in suckling mice.
    Chen Z; Liu LM; Gao N; Xu XF; Zhang JL; Wang JL; An J
    Curr Microbiol; 2009 Apr; 58(4):326-31. PubMed ID: 19189182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Eckels KH
    Am J Trop Med Hyg; 1987 Mar; 36(2):427-34. PubMed ID: 3826503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
    Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
    Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
    Lai CJ; Goncalvez AP; Men R; Wernly C; Donau O; Engle RE; Purcell RH
    J Virol; 2007 Dec; 81(23):12766-74. PubMed ID: 17881450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.
    Simantini E; Banerjee K
    Arch Virol; 1995; 140(7):1257-73. PubMed ID: 7646356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies raised to the dengue-2 virus (Cuban: A15 strain) which recognize viral structural proteins.
    Pupo-Antúnez M; Rodríguez H; Vázquez S; Vilaseca JC; Alvarez M; Otero A; Guzmán G
    Hybridoma; 1997 Aug; 16(4):347-53. PubMed ID: 9309425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of a dengue 1 sub-unit vaccine to protect mice against a lethal dengue virus infection.
    Aaskov JG; Williams L; Fletcher J; Hay R
    Am J Trop Med Hyg; 1988 Nov; 39(5):511-8. PubMed ID: 2973756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies.
    Bulich R; Aaskov JG
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2999-3003. PubMed ID: 1279106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
    Tang CT; Li PC; Liu IJ; Liao MY; Chiu CY; Chao DY; Wu HC
    PLoS Negl Trop Dis; 2015; 9(7):e0003903. PubMed ID: 26135599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
    Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
    J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.